Published in J Pediatr on May 01, 1967
25-Hydroxycholecalciferol. A comparative study in deficiency rickets and different types of resistant rickets. J Clin Invest (1972) 1.35
Biological activity of 25-hydroxycholecalciferol, a metabolite of vitamin D3. Proc Natl Acad Sci U S A (1968) 1.29
Metabolism of vitamin D3-3H in vitamin D-resistant rickets and familial hypophosphatemia. J Clin Invest (1967) 1.03
The biological activity of 25-hydroxycholecalciferol, a metabolite of vitamin D3. Proc Natl Acad Sci U S A (1968) 0.96
Pathogenesis of rickets and osteomalacia in familial hypophosphataemia. Arch Dis Child (1971) 0.78
Metabolic bone disease secondary to renal and intestinal disorders. Calif Med (1969) 0.75
A gene expression map for Caenorhabditis elegans. Science (2001) 9.74
Assay variation confounds the diagnosis of hypovitaminosis D: a call for standardization. J Clin Endocrinol Metab (2004) 6.41
Compulsory averaging of crowded orientation signals in human vision. Nat Neurosci (2001) 5.47
Current understanding of the molecular actions of vitamin D. Physiol Rev (1998) 4.05
Metabolism of vitamin D3-3H in human subjects: distribution in blood, bile, feces, and urine. J Clin Invest (1967) 3.69
Biologically active metabolite of vitamin D3 from bone, liver, and blood serum. J Lipid Res (1966) 3.39
25-hydroxycholecalciferol. A biologically active metabolite of vitamin D3. Biochemistry (1968) 3.01
1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. Proc Natl Acad Sci U S A (1996) 2.95
Biological activity of 25-hydroxyergocalciferol in rats. J Nutr (1970) 2.85
Expression of 1,25-dihydroxyvitamin D(3) receptor in the immune system. Arch Biochem Biophys (2000) 2.65
Target cells for 1,25-dihydroxyvitamin D3 in intestinal tract, stomach, kidney, skin, pituitary, and parathyroid. Science (1979) 2.57
1,25-dihydroxycholecalciferol: a potent stimulator of bone resorption in tissue culture. Science (1972) 2.50
Isolation and identification of 1,25-dihydroxycholecalciferol. A metabolite of vitamin D active in intestine. Biochemistry (1971) 2.50
Metabolism and mechanism of action of vitamin D. Annu Rev Biochem (1976) 2.49
Mechanism of action and metabolic fate of vitamin D. Vitam Horm (1967) 2.42
"Activation" of vitamin D by the liver. J Clin Invest (1969) 2.42
Regulation by calcium of in vivo synthesis of 1,25-dihydroxycholecalciferol and 21,25-dihydroxycholecalciferol. Proc Natl Acad Sci U S A (1971) 2.27
A sensitive, precise, and convenient method for determination of 1,25-dihydroxyvitamin D in human plasma. Arch Biochem Biophys (1976) 2.23
The role of the liver in the metabolism of vitamin D. J Clin Invest (1969) 2.22
Intestinal calcium absorption and serum vitamin D metabolites in normal subjects and osteoporotic patients: effect of age and dietary calcium. J Clin Invest (1979) 2.21
A rapid assay for 25-OH-vitamin D3 without preparative chromatography. J Clin Endocrinol Metab (1974) 2.20
A new chromatographic system for vitamin D3 and its metabolites: resoluation of a new vitamin D3 metabolite. J Lipid Res (1971) 2.12
1,25-Dihydroxycholecalciferol inhibits the progression of arthritis in murine models of human arthritis. J Nutr (1998) 2.06
Evidence that increased circulating 1 alpha, 25-dihydroxyvitamin D is the probable cause for abnormal calcium metabolism in sarcoidosis. J Clin Invest (1979) 2.02
Identification of a DNA sequence responsible for binding of the 1,25-dihydroxyvitamin D3 receptor and 1,25-dihydroxyvitamin D3 enhancement of mouse secreted phosphoprotein 1 (SPP-1 or osteopontin) gene expression. Proc Natl Acad Sci U S A (1990) 1.99
Vitamin D: recent advances. Annu Rev Biochem (1983) 1.99
The synthesis of [1,2-3H]vitamin D3 and the tissue localization of a 0.25-mu-g (10 IU) dose per rat. Biochemistry (1966) 1.99
IgG-Fc-mediated effector functions: molecular definition of interaction sites for effector ligands and the role of glycosylation. Immunol Rev (1998) 1.98
Vitamin D metabolism: the role of kidney tissue. Science (1971) 1.91
Normal function and lack of fibronectin accumulation in kidneys of Clara cell secretory protein/uteroglobin deficient mice. Am J Kidney Dis (1999) 1.89
Vitamin D deficiency suppresses cell-mediated immunity in vivo. Arch Biochem Biophys (1993) 1.89
Regulation of vitamin D metabolism and function. Physiol Rev (1973) 1.88
Isolation and characterization of a novel cDNA from HL-60 cells treated with 1,25-dihydroxyvitamin D-3. Biochim Biophys Acta (1994) 1.85
Identification of 1,25-dihydroxycholecalciferol, a form of vitamin D3 metabolically active in the intestine. Proc Natl Acad Sci U S A (1971) 1.78
Biological activity of 1,25-dihydroxycholecalciferol. Biochemistry (1971) 1.77
DNA sequences in the rat osteocalcin gene that bind the 1,25-dihydroxyvitamin D3 receptor and confer responsiveness to 1,25-dihydroxyvitamin D3. Proc Natl Acad Sci U S A (1990) 1.77
Relationship between peripheral airway dysfunction, airway obstruction, and neutrophilic inflammation in COPD. Thorax (2004) 1.69
Cloning of the human 1 alpha,25-dihydroxyvitamin D-3 24-hydroxylase gene promoter and identification of two vitamin D-responsive elements. Biochim Biophys Acta (1995) 1.69
21,25-dihydroxycholecalciferol. A metabolite of vitamin D3 preferentially active on bone. Biochemistry (1970) 1.65
Monoclonal antibodies to the porcine intestinal receptor for 1,25-dihydroxyvitamin D3: interaction with distinct receptor domains. Biochemistry (1986) 1.64
Isolation and identification of 24,25-dihydroxycholecalciferol, a metabolite of vitamin D made in the kidney. Biochemistry (1972) 1.62
25-Hydroxycholecalciferol-1-hydroxylase. Subcellular location and properties. J Biol Chem (1972) 1.62
Subcellular location of vitamin D and its metabolites in intestinal mucosa after a 10-IU dose. Biochemistry (1967) 1.61
Assessing daily management in childhood diabetes. Health Psychol (1986) 1.60
1 alpha,25-Dihydroxyvitamin D3 and 1 alpha-hydroxyvitamin D3 prolong survival time of mice inoculated with myeloid leukemia cells. Proc Natl Acad Sci U S A (1983) 1.60
Vitamin-D-dependent rickets type II. Resistance of target organs to 1,25-dihydroxyvitamin D. N Engl J Med (1978) 1.59
25-hydroxycholecalciferol. The probable metabolically active form of vitamin D3: its identification and subcellular site of action. Arch Intern Med (1969) 1.58
Determination of vitamin D and its metabolites in plasma from normal and anephric man. Biochem J (1979) 1.58
The kidney as an endocrine organ for the production of 1,25-dihydroxyvitamin D 3 , a calcium-mobilizing hormone. N Engl J Med (1973) 1.54
The influence of glycosylation on the thermal stability and effector function expression of human IgG1-Fc: properties of a series of truncated glycoforms. Mol Immunol (2001) 1.51
Pathogenesis of hereditary vitamin-D-dependent rickets. An inborn error of vitamin D metabolism involving defective conversion of 25-hydroxyvitamin D to 1 alpha,25-dihydroxyvitamin D. N Engl J Med (1973) 1.50
Role of oligosaccharide residues of IgG1-Fc in Fc gamma RIIb binding. J Biol Chem (2001) 1.48
In vitro production of 25-hydroxycholecalciferol. Biochem Biophys Res Commun (1969) 1.48
Mitochondrial cytochrome p450. A component of chick kidney 25-hydrocholecalciferol-1alpha-hydroxylase. J Biol Chem (1974) 1.45
Rat intestinal 25-hydroxyvitamin D3- and 1alpha,25-dihydroxyvitamin D3-24-hydroxylase. J Biol Chem (1978) 1.44
Current concepts. Vitamin D. N Engl J Med (1969) 1.43
Dietary calcium is a major factor in 1,25-dihydroxycholecalciferol suppression of experimental autoimmune encephalomyelitis in mice. J Nutr (1999) 1.41
1,25-dihydroxyvitamin D3 is a positive regulator for the two anti-encephalitogenic cytokines TGF-beta 1 and IL-4. J Immunol (1998) 1.41
Sequences in the human parathyroid hormone gene that bind the 1,25-dihydroxyvitamin D3 receptor and mediate transcriptional repression in response to 1,25-dihydroxyvitamin D3. Proc Natl Acad Sci U S A (1992) 1.41
Inappropriate emergency department visits. Ann Emerg Med (1985) 1.40
25,26-dihydroxycholecalciferol, a metabolite of vitamin D3 with intestinal calcium transport activity. Biochemistry (1970) 1.40
Solution structure of a mammalian PCB-binding protein in complex with a PCB. Nat Struct Biol (1995) 1.40
Serum 1,25-dihydroxyvitamin D levels in normal subjects and in patients with hereditary rickets or bone disease. N Engl J Med (1978) 1.40
A critical look at a critical review. J Pediatr Endocrinol Metab (1998) 1.39
[Flucticasone propionate is safe in recommended doses]. Lakartidningen (1997) 1.39
The vitamin D system in the regulation of calcium and phosphorus metabolism. Nutr Rev (1979) 1.39
A specific high-affinity binding macromolecule for 1,25-dihydroxyvitamin D3 in fetal bone. Science (1977) 1.38
Parathyroid hormone activation of the 25-hydroxyvitamin D3-1alpha-hydroxylase gene promoter. Proc Natl Acad Sci U S A (1998) 1.38
Induction of macrophage differentiation of human normal and leukemic myeloid stem cells by 1,25-dihydroxyvitamin D3 and its fluorinated analogues. Cancer Res (1984) 1.37
Effect of estrogen on calcium absorption and serum vitamin D metabolites in postmenopausal osteoporosis. J Clin Endocrinol Metab (1980) 1.37
Vitamin D: the vitamin and the hormone. Fed Proc (1974) 1.36
Vitamin D stimulated, calcium-dependent adenosine triphosphatase from brush borders of rat small intestine. Biochem Biophys Res Commun (1969) 1.35
Stimulation of 25-hydroxyvitamin D3-1alpha-hydroxylase by phosphate depletion. J Biol Chem (1976) 1.34
Reduction in 1,25-dihydroxyvitamin D in children with increased lead absorption. N Engl J Med (1980) 1.34
A comparative study of the N-linked oligosaccharide structures of human IgG subclass proteins. Biochem J (1990) 1.33
Stimulation of 24,25-dihydroxyvitamin D3 production by 1,25-dihydroxyvitamin D3. Science (1974) 1.33
Treatment of hypoparathyroidism and pseudohypoparathyroidism with metabolites of vitamin D: evidence for impaired conversion of 25-hydroxyvitamin D to 1 alpha,25-dihydroxyvitamin D. N Engl J Med (1975) 1.33
Absence of seasonal variation in serum concentrations of 1,25-dihydroxyvitamin D despite a rise in 25-hydroxyvitamin D in summer. J Clin Endocrinol Metab (1981) 1.32
Influence of sodium on calcium transport by the rat small intestine. Am J Physiol (1969) 1.31
Direct chemical synthesis of 1 alpha,25-dihydroxy[26,27-3H]vitamin D3 with high specific activity: its use in receptor studies. Biochemistry (1980) 1.30
Subcellular location of rat liver calciferol-25-hydroxylase. Arch Biochem Biophys (1974) 1.29
Identification of the porcine intestinal 1,25-dihydroxyvitamin D3 receptor on sodium dodecyl sulfate/polyacrylamide gels by renaturation and immunoblotting. Proc Natl Acad Sci U S A (1985) 1.29
Biological activity of 25-hydroxycholecalciferol, a metabolite of vitamin D3. Proc Natl Acad Sci U S A (1968) 1.29
The role of vitamin D and its relationship to parathyroid hormone and calcitonin. Recent Prog Horm Res (1971) 1.28
Vitamin D is not directly necessary for bone growth and mineralization. Am J Physiol (1984) 1.28
25-Hydroxyvitamin D3-24-hydroxylase. Subcellular location and properties. Biochemistry (1974) 1.28
Rickets with alopecia: an inborn error of vitamin D metabolism. J Pediatr (1979) 1.27
1,25-dihydroxycholecalciferol: metabolite of vitamin D3 active on bone in anephric rats. Science (1972) 1.26
Association between age, blood lead concentration, and serum 1,25-dihydroxycholecalciferol levels in children. Am J Clin Nutr (1982) 1.26
1,25-Dihydroxyvitamin D in biological fluids: a simplified and sensitive assay. Science (1976) 1.26
Role of vitamin D metabolites in phosphate transport of rat intestine. J Nutr (1974) 1.25
Evidence of an age-related decrease in intestinal responsiveness to vitamin D: relationship between serum 1,25-dihydroxyvitamin D3 and intestinal vitamin D receptor concentrations in normal women. J Clin Endocrinol Metab (1992) 1.24
1 alpha,25-dihydroxyvitamin D3 promotes fusion of mouse alveolar macrophages both by a direct mechanism and by a spleen cell-mediated indirect mechanism. Proc Natl Acad Sci U S A (1983) 1.24
Metaboism of 25-hydroxycholecalciferol in target and nontarget tissues. Biochemistry (1970) 1.24
Effects of adductor-canal-blockade on pain and ambulation after total knee arthroplasty: a randomized study. Acta Anaesthesiol Scand (2012) 1.24
Effect of I,25-dihydroxycholecalciferol in renal osteodystrophy. Can Med Assoc J (1975) 1.24
Effect of vitamin D deficiency on fertility and reproductive capacity in the female rat. J Nutr (1980) 1.22
Aglycosylation of human IgG1 and IgG3 monoclonal antibodies can eliminate recognition by human cells expressing Fc gamma RI and/or Fc gamma RII receptors. Biochem J (1989) 1.22